Analysts' average 12-month price target for Anterix is $69.
Get informed when a big investor buys or sells
+ Follow$92.79
1 analysts in the last 4 months
High: $69 | Low: $69
No recommendations in the last 4 months.
Anterix (ATEX) currently reports a target price of $69. Use the charts on this page to explore Anterix's target price history and peer comparisons.
Analysts' average 12-month price target for Anterix is $69, about 25.6% downside from the current share price of $92.79. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.
Start with the current target price of $69, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anterix, and consider following ATEX for alerts when major investors trade the stock.
Anterix is classified in the Technology sector. On target price, it currently shows $69. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ATEX with unrelated industries.